Estimation of Paracetamol in Urine to Assess the Diurnal Variation

Diurnal Variation of Paracetamol Excretion Clinical Trial

Official title:

Estimation of Paracetamol in Urine to Assess the Diurnal Variation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03122561
• Other study ID #: BSMMU-013-CT
• Status: Completed
• Phase: N/A
• Start date: November 3, 2016
• Est. completion date: January 30, 2018

Study information

• Verified date: July 2018
• Source: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Paracetamol is an antipyretic drug that is taken orally at different times of the day in same dose. It is excreted mainly through renal route which may show diurnal variation. In this study, urinary excretion of paracetamol of 41 healthy men of same age group will be measured by HPLC after oral administration of 500 mg paracetamol tablet at morning, midday and night. The measured values will be compared in order to adjust doses of oral paracetamol at different times of the day.

Description:

Drug absorption, distribution, biotransformation and excretion are influenced by many different physiological functions of the body which may vary with time of the day. The time dependent changes in pharmacokinetics are due to circadian variation of human physiology and it is sometimes responsible for drug effects or adverse effects. Paracetamol is a widely used antipyretic and analgesic drug. It is usually well tolerated when used at the recommended dose. Paracetamol is a weak acidic drug that is rapidly absorbed and distributed after oral administration. It is metabolized extensively in liver and excrteted mainly through kidney as metabolites of paracetamol and some are as unchanged form. Paracetamol and its metabolites can be determined in biological fluids (urine, plasma, serum) by various mechanisms. High Performance Liquid Chromatography (HPLC) is a modern analytical chemistry technique by which paracetamol can be identified, separated and estimated from urine sample. This study is designed to investigate whether the excretion of paracetamol is changed or not if administered at same dose as oral tablet at three different times of the day. For this purpose after taking written informed consent 41 healthy men of aged 19- 23 will be provided 500 mg oral paracetamol tablet at morning, midday and night in two weeks interval and estimation of urinary paracetamol will be done by HPLC after paracetamol ingestion. A pilot study has been done and result shows highest concentration of paracetamol in urine after its oral administration found at 4th hour. Urine sample will be collected before and 4 hour after paracetamol administration in chloroform containing urine container and will be preserved in - 20 ̊C until analysis. Paracetamol standard has been collected from the same pharmaceutical company of which the drug will be used for study. Mobile phase will be consist of acetonitrile and distilled water and flow rate will be 0.5 ml/min at 25 ̊C temperature and 900 Psi pressure. The standard and sample will be analysed at a wavelength 254 nm. Total urinary paracetamol of that time will be estimated by multiplying total urinary volume in ml and concentration of paracetamol in one ml of urine. After measuring paracetamol at different times of the day, statistical analysis will be done to compare those values. If significant variation is found, adjustment of dose of oral paracetamol in different time of the day will be tried.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 46
• Est. completion date: January 30, 2018
• Est. primary completion date: January 30, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 19 Years to 23 Years

Eligibility

Inclusion Criteria:

• The healthy male student volunteers of Eastern Medical College having age range between 19 and 23 years

Exclusion Criteria:

• Age <19 years , >23 years

• Volunteers on analgesic or antipyretic medication

• Volunteers with history of hypersensitivity to paracetamol

• Volunteers taking any enzyme inducing or enzyme inhibiting drug

• Volunteers with impaired renal or hepatic function

Related Conditions & MeSH terms

• Diurnal Variation of Paracetamol Excretion

Intervention

Drug:
• Paracetamol 500 mg tablet at morning
Single dose oral paracetamol will be administered at 8.00 am
• Paracetamol 500 mg tablet at midday
Single dose oral paracetamol will be administered at 2.00 pm
• Paracetamol 500 mg tablet at night
Single dose oral paracetamol will be administered at 8.00 pm

Locations

Country	Name	City	State
Bangladesh	Eastern Medical College	Comilla

Sponsors (1)

Lead Sponsor	Collaborator
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Country where clinical trial is conducted

Bangladesh, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in the amount of urinary paracetamol in different times	Changes in the amount of urinary paracetamol in different times (morning, midday and night) 4 hours after oral administration of 500 mg of paracetamol	[Morning: 0 hour (baseline), 4 hour (end); Mid-day: 0 hour (baseline), 4 hour (end); Night: 0 hour (baseline), 4 hour (end)] [Safety Issue: No]